Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gray

Showing results (1141-1150 of 1,555) with videos related to

Pageof 156
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantationM G Levisetti, P A Padrid, G L Szot, et al.
Cancer Discovery|December 28, 2014
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanomaBenchun Miao, Zhenyu Ji, Li Tan, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Benzopyrimidodiazepinone inhibitors of TNK2Brian J Groendyke, Chelsea E Powell, Frederic Feru, et al.
Developmental Biology|December 8, 2020
Postembryonic screen for mutations affecting spine development in zebrafishRyan S Gray, Roberto Gonzalez, Sarah D Ackerman, et al.
Journal of Medicinal Chemistry|June 13, 2020
Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6<i>H</i>-benzo[<i>e</i>]pyrimido[5,4-<i>b</i>][1,4]diazepin-6-one ScaffoldFleur M Ferguson, Yan Liu, Wayne Harshbarger, et al.
Science Signaling|October 30, 2014
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastomaGanesh Umapathy, Abeer El Wakil, Barbara Witek, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
VerteBrain reveals novel neural and non-neural protein assemblies conserved across vertebrate evolutionVy Dang, Brittney Voigt, David Yang, et al.
Journal of Medicinal Chemistry|November 23, 2022
Development and Utility of a PAK1-Selective DegraderHoi-Yee Chow, Sofiia Karchugina, Brian J Groendyke, et al.
Journal of Psychopharmacology (Oxford, England)|February 10, 2000
Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteersV Kumari, P A Cotter, O F Mulligan, et al.
Cell Chemical Biology|October 11, 2022
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferationInchul You, Katherine A Donovan, Noah M Krupnick, et al.
Pageof 156

Showing results (1141-1150 of 1,555) with videos related to

Sort By:
Pageof 156
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 1998
Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantationM G Levisetti, P A Padrid, G L Szot, et al.
Cancer Discovery|December 28, 2014
EPHA2 is a mediator of vemurafenib resistance and a novel therapeutic target in melanomaBenchun Miao, Zhenyu Ji, Li Tan, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2020
Benzopyrimidodiazepinone inhibitors of TNK2Brian J Groendyke, Chelsea E Powell, Frederic Feru, et al.
Developmental Biology|December 8, 2020
Postembryonic screen for mutations affecting spine development in zebrafishRyan S Gray, Roberto Gonzalez, Sarah D Ackerman, et al.
Journal of Medicinal Chemistry|June 13, 2020
Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6<i>H</i>-benzo[<i>e</i>]pyrimido[5,4-<i>b</i>][1,4]diazepin-6-one ScaffoldFleur M Ferguson, Yan Liu, Wayne Harshbarger, et al.
Science Signaling|October 30, 2014
The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastomaGanesh Umapathy, Abeer El Wakil, Barbara Witek, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
VerteBrain reveals novel neural and non-neural protein assemblies conserved across vertebrate evolutionVy Dang, Brittney Voigt, David Yang, et al.
Journal of Medicinal Chemistry|November 23, 2022
Development and Utility of a PAK1-Selective DegraderHoi-Yee Chow, Sofiia Karchugina, Brian J Groendyke, et al.
Journal of Psychopharmacology (Oxford, England)|February 10, 2000
Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteersV Kumari, P A Cotter, O F Mulligan, et al.
Cell Chemical Biology|October 11, 2022
Acute pharmacological degradation of ERK5 does not inhibit cellular immune response or proliferationInchul You, Katherine A Donovan, Noah M Krupnick, et al.
Pageof 156